Mirae Asset Global ETFs Holdings Portfolio holdings
AUM
$51.7B
1-Year Return
33.71%
This Quarter Return
-2.86%
1 Year Return
+33.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$46.9B
AUM Growth
-$324M
(-0.69%)
Cap. Flow
+$2.36B
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
20%
Holding
3,117
New
62
Increased
2,462
Reduced
519
Closed
61
Top Buys
| 1 |
CRH
CRH
|
$249M |
| 2 |
Apple
AAPL
|
$135M |
| 3 |
Palantir
PLTR
|
$135M |
| 4 |
Microsoft
MSFT
|
$114M |
| 5 |
TSMC
TSM
|
$83.2M |
Top Sells
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$171M |
| 2 |
Howmet Aerospace
HWM
|
$79.7M |
| 3 |
Cameco
CCJ
|
$77.2M |
| 4 |
Trane Technologies
TT
|
$66.3M |
| 5 |
ALTM
Arcadium Lithium plc
ALTM
|
$61M |
Sector Composition
| 1 | Technology | 25.82% |
| 2 | Industrials | 17.62% |
| 3 | Energy | 13.93% |
| 4 | Materials | 9.29% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Telomir Pharmaceuticals
TELO
$40M
| $36.1K | ﹤0.01% |
11,167
+468
| +4% | +$1.51K |
|
2902
Traeger
COOK
$200M
| $36K | ﹤0.01% |
21,428
+858
| +4% | +$1.44K |
|
2903
Emerald Holding
EEX
$1.02B
| $35.5K | ﹤0.01% |
9,039
+390
| +5% | +$1.53K |
|
2904
Cemex
CX
$13.6B
| $35.4K | ﹤0.01% |
6,315
-1,582
| -20% | -$8.88K |
|
2905
Biomea Fusion
BMEA
$114M
| $35.2K | ﹤0.01% |
16,531
+702
| +4% | +$1.5K |
|
2906
SWK Holdings
SWKH
$178M
| $34.9K | ﹤0.01% |
2,533
+99
| +4% | +$1.36K |
|
2907
InnovAge Holding
INNV
$512M
| $34.8K | ﹤0.01% |
11,688
+468
| +4% | +$1.4K |
|
2908
Greenwich LifeSciences
GLSI
$149M
| $34.7K | ﹤0.01% |
3,638
+156
| +4% | +$1.49K |
|
|
ARTV
2909
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$88.2M
| $34.4K | ﹤0.01% |
11,477
+3,438
| +43% | +$10.3K |
|
2910
FiscalNote
NOTE
$58.7M
| $34.4K | ﹤0.01% |
3,545
+564
| +19% | +$5.47K |
|
2911
Inovio Pharmaceuticals
INO
$148M
| $33.9K | ﹤0.01% |
20,781
+5,894
| +40% | +$9.61K |
|
2912
NET Power
NPWR
$171M
| $33.6K | ﹤0.01% |
12,786
+546
| +4% | +$1.44K |
|
2913
GoHealth
GOCO
$76.9M
| $32.9K | ﹤0.01% |
2,679
+78
| +3% | +$957 |
|
2914
Vera Bradley
VRA
$60.6M
| $32.8K | ﹤0.01% |
14,594
+624
| +4% | +$1.4K |
|
2915
FTI Consulting
FCN
$5.46B
| $32.8K | ﹤0.01% |
+200
| New | +$32.8K |
|
2916
Ultralife
ULBI
$119M
| $32.2K | ﹤0.01% |
5,983
+234
| +4% | +$1.26K |
|
2917
Gyre Therapeutics
GYRE
$698M
| $32.2K | ﹤0.01% |
4,169
+156
| +4% | +$1.2K |
|
2918
TScan Therapeutics
TCRX
$108M
| $32.1K | ﹤0.01% |
23,238
+1,024
| +5% | +$1.41K |
|
2919
Olin
OLN
$2.9B
| $31.9K | ﹤0.01% |
+1,317
| New | +$31.9K |
|
2920
Sutro Biopharma
STRO
$89.9M
| $31.9K | ﹤0.01% |
48,998
+2,112
| +5% | +$1.37K |
|
2921
Stem
STEM
$117M
| $31.9K | ﹤0.01% |
4,550
+192
| +4% | +$1.35K |
|
2922
Lexicon Pharmaceuticals
LXRX
$396M
| $31.6K | ﹤0.01% |
68,683
+2,901
| +4% | +$1.34K |
|
|
AVR
2923
Anteris Technologies Global Corp. Common Stock
AVR
$150M
| $31.6K | ﹤0.01% |
+8,689
| New | +$31.6K |
|
2924
LiveOne
LVO
$51.2M
| $31.3K | ﹤0.01% |
44,823
+1,875
| +4% | +$1.31K |
|
2925
Sibanye-Stillwater
SBSW
$6.08B
| $31.1K | ﹤0.01% |
7,100
-1,076
| -13% | -$4.71K |
|